Plasma prefractionation methods for proteomic analysis and perspectives in clinical applications. Chutipongtanate S*, Chatchen S, Svasti J. Proteomics Clin Appl 2017;11(7-8):1600135.

01 Jul 2017
0
0

Plasma prefractionation methods for proteomic analysis and perspectives in clinical applications.

Chutipongtanate S*, Chatchen S, Svasti J.

Proteomics Clin Appl 2017;11(7-8):1600135.

Tags

Share this

Related Posts

Molee, W.; Phanumartwiwath, A.; Kesornpun, C.; Sureram, S.; Ngamrojanavanich, N.; Ingkaninan, K.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Naphthalene Derivatives and Quinones from Ventilago denticulata and Their Nitric Oxide Radical Scavenging, Antioxidant, Cytotoxic, Antibacterial, and Phosphodiesterase Inhibitory Activities. Chem. Biodivers. 2018, 15(3):e, 1700537.
28 Dec 2018
0

Molee, W.; Phanumartwiwath, A.; Kesornpun, C.; Sureram, S.; Ngamrojanavanich, N.; Ingkaninan, K.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Naphthalene Derivatives and Quinones from Ventilago denticulata and Their Nitric Oxide Radical Scavenging, Antioxidant, Cytotoxic, Antibacterial, and Phosphodiesterase Inhibitory Activities. Chem. Biodivers. 2018, 15(3):e, 1700537.

Molee, W.; Phanumartwiwath, A.; Kesornpun, C.; Sureram, S.; Ngamrojanavanich, N.; Ingkaninan, K.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Naphthalene Derivatives and Quinones from Ventilago denticulata and Their Nitric Oxide Radical Scavenging, Antioxidant, Cytotoxic, Antibacterial, and Phosphodiesterase Inhibitory Activities. Chem. Biodivers. 2018, 15(3):e, 1700537.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More